Rapid In Vivo Validation of HDAC Inhibitor-Based Treatments in Neuroblastoma Zebrafish Xenografts

The survival rate among children with relapsed neuroblastomas continues to be poor, and thus new therapeutic approaches identified by reliable preclinical drug testing models are urgently needed. Zebrafish are a powerful vertebrate model in preclinical cancer research. Here, we describe a zebrafish...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrobel, Jagoda K, Najafi, Sara, Ayhan, Simay, Gatzweiler, Charlotte, Krunic, Damir, Ridinger, Johannes, Milde, Till, Westermann, Frank, Peterziel, Heike, Meder, Benjamin, Distel, Martin, Witt, Olaf, Oehme, Ina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692187/
https://www.ncbi.nlm.nih.gov/pubmed/33121173
http://dx.doi.org/10.3390/ph13110345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692187/
https://www.ncbi.nlm.nih.gov/pubmed/33121173
http://dx.doi.org/10.3390/ph13110345

Ejemplares similares